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S U M M A R Y
Crimean-Congo hemorrhagic fever virus (CCHFV) etiology was detected in a family cluster (nine cases,
including two deaths) in the village of Karyana, Amreli District, and also a fatal case in the village of
Undra, Patan District, in Gujarat State, India. Anti-CCHFV IgG antibodies were detected in domestic
animals from Karyana and adjoining villages. Hyalomma ticks from households were found to be positive
for CCHF viral RNA. This conﬁrms the emergence of CCHFV in new areas and the wide spread of this
disease in Gujarat State.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Crimean-Congo hemorrhagic fever (CCHF) is a severe acute
febrile illness caused by the CCHF virus (CCHFV), with an overall
case fatality of 9–50%.1,2 CCHFV is widespread in Africa, Asia,
Southeast Europe and the Middle East.1,3 CCHF was ﬁrst conﬁrmed
in India during 2010–2011, in Ahmadabad, Gujarat.4 Person-to-
person transmission and instances of nosocomial transmission
were conﬁrmed during 2010 (two cases), 2011 (eight cases), and
2012 (three cases).5,6 In this article we describe a series of cases in
an outbreak of CCHF occurring in Amreli District, Gujarat State
during June–July 2013.* Corresponding author. Tel.: +91 20 26006201; fax: +91 20 26122669.
E-mail addresses: directorniv@gmail.com, dtmourya@gmail.com (D.T. Mourya).
1201-9712  2013 The Authors. Published by Elsevier Ltd on behalf of International S
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During the period June 23 to July 25, 2013, a cluster of suspected
viral hemorrhagic fever (VHF) cases were reported in the village of
Karyana, Amreli District, Gujarat State, India. There were fourteen
reported cases, of which ﬁve were fatal. The primary case (case A)
was a 90-year-old man, who presented on June 23 with fever,
diarrhea, blood in the stools, and severe abdominal pain. After
initial treatment at Amreli District Hospital, he died on June 25. His
grandson (age 13 years, case B) was an index case who had close
contact with case A and had a history of tick bite; he presented
with fever on June 27. The wife of case A (age 85 years, case C) and
his three daughters-in-law (age 60 years, case D; age 45 years, case
E; age 23 years, case F) also developed fever (June 30) and
hemorrhagic symptoms and signs (petechiae, per vaginal bleed-
ing). Subsequently, another daughter-in-law (age 22 years, case G)
and a son (age 40 years, case H) presented with fever and
hemorrhagic symptoms and signs on July 2 and July 3, respectively.
During the sickness period and during the funeral of case A, family
members along with cases (B, C, D, E, F, G, H, I, J, K, L, M, and N) had
regularly visited and stayed at the residence of case A (Table 1 and
Fig. 1). Close family member contacts (n = 75), along with familyociety for Infectious Diseases. Open access under CC BY-NC-SA license.
Table 1
CCHFV detection in viral hemorrhagic fever cases from in Karyana and Undra village, Gujarat, India



















NA A M 90 Karyana 23-Jun-13 NA NA NA NA NA Died 25-Jun-13
NIV1310777 B M 13 Karyana 27-Jun-13 8-Jul-13 11 Positive (38) Positive Positive Recovered 19-Jul-13
NA C F 85 Karyana 30-Jun-13 NA NA NA NA NA Died 2-Jul-13
NIV1310780 D F 60 Karyana 30-Jun-13 6-Jul-13 6 Positive (22.5) Positive Negative Died 6-Jul-13
NIV1310779 E F 45 Karyana 30-Jun-13 7-Jul-13 7 Positive (29.7) Positive Positive Recovered 17-Jul-13
NA F F 23 Karyana 30-Jun-13 NA NA NA NA NA Died 4-Jul-13
NIV1310778 G F 22 Karyana 2-Jul-13 8-Jul-13 6 Positive (32.5) Positive Positive Recovered 19-Jul-13
NIV1310776 H M 40 Karyana 3-Jul-13 7-Jul-13 4 Positive (22.5) Positive Negative Died 9-Jul-13
NIV1311991 I F 35 Karyana 2-Jul-13 24-Jul-13 22 Negative Negative Negative Recovered 29-Jul-13
NIV1310806 J M 23 Karyana 7-Jul-13 9-Jul-13 2 Positive (21.5) Positive Negative Recovered 23-Jul-13
NIV1311122 K F 50 Karyana 8-Jul-13 15-Jul-13 7 Positive (29) Positive Negative Recovered 27-Jul-13
NIV1310923 L M 45 Karyana 8-Jul-13 11-Jul-13 3 Negative Negative Negative Recovered 19-Jul-13
NIV1311437 M F 50 Karyana 10-Jul-13 16-Jul-13 6 Positive (29.5) Positive Negative Recovered 26-Jul-13
NIV1311581 N F 35 Karyana 16-Jul-13 20-Jul-13 4 Positive (30) Positive ND Recovered 31-Jul-13
NIV1311579 O F 68 Undra (Patan) 11-Jul-13 18-Jul-13 7 Positive (30.4) Positive Negative Died 20-Jul-13
CCHFV, Crimean-Congo hemorrhagic fever virus; NIV, National Institute of Virology; POD, post-onset day of testing the serum; Ct, cycle threshold; M, male; F, female; NA,
sample not available; ND, not done.
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case during the funeral and other rituals following his death
(Fig. 1). The secondary attack rate was 3.7% and the primary attack
rate was 0.3%.Figure 1. Geographical distribution of Crimean-Congo hemorrhagic fever cases in Case C died on post-onset day 2 due to cardio-respiratory arrest
and case F died on post-onset day 4 due to hemorrhagic shock.
Serum samples from suspected VHF cases were tested for dengue
NS1 and IgM antibody and were referred to the National Institutethe villages of Karyana, Amreli District, and Undra, Patan District, in Gujarat.
Table 2
Anti-CCHFV IgG antibody positivity in animals from Karyana village in Amreli,
Gujarat, India
Village Animal Total tested IgG positive % Positivity
Karyana Cattle 23 10 43.7
Goats 4 4 100
Sheep 6 6 100
Total 33 20 60.6
Khambala Buffalo 3 0 0
Cattle 4 2 50
Goats 8 3 37.5
Sheep 5 3 60
Total 20 8 40
Nilwada Cattle 5 2 40
Goats 16 6 37.5
Sheep 8 0 0
Total 29 8 27.5
Grand total 82 36 43.9
CCHFV, Crimean-Congo hemorrhagic fever virus.
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samples were collected from VHF (n = 11) and fever cases (n = 26)
reported in the village of Karyana during this period. The clinical
sample from a VHF case (case O) in the village of Undra, Patan
District was also referred to the NIV, Pune (Fig. 1).
The clinical features observed in VHF patients included high-
grade fever, headache, body aches, malaise, diarrhea, abdominal
pain, nausea, vomiting, petechiae, ecchymosis, bleeding per
rectum and per vagina, and hematemesis, as reported previous-
ly.4,5 The laboratory ﬁndings of VHF patients were elevated
prothrombin time (PT), activated partial thromboplastin time
(aPTT), alanine aminotransferase (ALT), aspartate aminotransfer-
ase (AST), lactate dehydrogenase (LDH), and creatine phosphoki-
nase (CPK), leukopenia, and thrombocytopenia, as well as
signiﬁcantly raised ﬁbrinogen degradation products (FDP) and
D-dimer levels.
Samples from domestic animals (cattle, sheep, and goats) and
infested ticks from the vicinity of the index case (case A) (Karyana
and neighboring villages) were collected by the authorities of the
Animal Husbandry Department and National Vector Borne Disease
Control Programme (NVBDCP) (Table 2). A total of 138 ticks were
collected from Karyana, 94 from Nilwada, and 139 from Khambala
and were classiﬁed and pooled in 30 groups (Supplementary
Material, Table S1).
Human, tick, and animal samples were processed in a biosafety
level 4 laboratory at NIV, Pune and tested for CCHFV and Kyasanur
Forest disease virus by real-time RT-PCR, RT-PCR, and IgM ELISA.5–9
The CCHFV etiology was conﬁrmed in 10 cases (three deaths),
including the fatal case from Patan District (Fig. 1). Serum samples
collected from fever cases (n = 26) were found negative for CCHFV,
while anti-dengue IgM antibodies were detected in two fever cases.
Hyalomma anatolicum anatolicum pools (n = 5) collected from
livestock around the village of Karyana were found positive by RT-
PCR and real-time RT-PCR. Livestock blood samples (n = 95) were
found negative for CCHFV. A 226-bp fragment of the S segment
generated from CCHF-positive human samples and tick pools
showed that the CCHFV detected in Karyana had maximum
nucleotide identity (99.0%) with the Ahmadabad strain of the 2011
outbreak sequences and belongs to Asian/Middle East genetic
lineage IV.5–7 CCHFV-speciﬁc IgG positivity was found in livestock
(cattle, goats, and sheep) from the villages of Karyana, Nilwada,
and Khambala (Table 2). The overall IgG antibody positivity in the
animals was 43.9%.
3. Discussion
The likely source of the CCHF identiﬁed in the village of
Karyana, Amreli District was virus-infected Hyalomma ticks andlivestock at the residence of the primary case (case A). Domestic
animal positivity for IgG antibodies in Karyana and surrounding
villages and the human case positivity in Patan District conﬁrms
that CCHF is widely present in this region. The presence of anti-
dengue IgM antibodies among fever cases reported in the village
also conﬁrms the underlying dengue activity in the area. The
isolation of human cases, treatment in hospital by instituting
ribavirin timely replacement of blood components, universal
precautions, contact tracing and surveillance of fever cases and
insecticidal spray as an anti-tick measure, initiated in the affected
village and neighboring villages, helped to contain the focal
outbreak.
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